0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Consequence of Neonatal Androgenization and Castration for Future Levels of Norepinephrine Transmitter in Uterus and Vas Deferens of the Rat

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Castration of male rats immediately afterbirth, which induces a permanent femininization of reproductive function, resulted in a marked reduction in the weight and total organ content of norepinephrine in the vasa deferentia as measured before and after sexual maturation. The norepinephrine fall was about 3-fold greater than after castration of adult animals. Androgenìzation of female rats by a single injection of testosterone propionate on the 5th day post partum did not affect uterine weight, but significantly lowered total organ content of norepinephrine when measured before and after sexual maturation. It is suggested that the vasa deferentia and uterus contain a population of adrenergic nerves, probably identical with or part of the system of ‘short adrenergic neurons’ that constitute a separate target system for those humoral factors which determine the pattern of development of the reproductive tract by influencing the early differentiation of the hypothalamus.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1974
          1974
          25 March 2008
          : 15
          : 5
          : 308-312
          Affiliations
          Departments of Histology, and Obstetrics and Gynecology, University of Lund, Lund
          Article
          122320 Neuroendocrinology 1974;15:308–312
          10.1159/000122320
          4431559
          © 1974 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 5
          Categories
          Paper

          Comments

          Comment on this article